You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 8, 2024

Litigation Details for United States v. Gilead Sciences, Inc. (D. Del. 2019)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in United States v. Gilead Sciences, Inc.
The small molecule drugs covered by the patents cited in this case are ⤷  Sign Up , ⤷  Sign Up , ⤷  Sign Up , ⤷  Sign Up , ⤷  Sign Up , ⤷  Sign Up , ⤷  Sign Up , ⤷  Sign Up , ⤷  Sign Up , ⤷  Sign Up , ⤷  Sign Up , and ⤷  Sign Up .
Biologic Drugs cited in United States v. Gilead Sciences, Inc.
The biologic drug covered by the patents cited in this case is ⤷  Sign Up .

Details for United States v. Gilead Sciences, Inc. (D. Del. 2019)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 External link to document
2022-12-05 370 Exhibit REDACTED Ex A-Z .S. Patent No. 7,803,788 lists “Gilead Sciences, Inc.” as the assignee. Claim 7 of this patent recites…509 Patent, the ’333 Patent, the ’191 Patent, and the ’423 Patent (collectively, the “Patents-in-Suit… 13 of the ‘509 Patent, claim 13 of the ‘333 Patent, claim 13 of the ’191 Patent, and claim 12 of the…claim 13 of the ’509 Patent, claim 13 of the ’333 Patent, claim 13 of the ’191 Patent, and claim 12 of …from the different patents: ’509 Patent ’333 Patent External link to document
2023-04-03 422 Exhibit A-I 5,914,331; 5,922,695; 5,935,946; 5,977,089; 6,043,230; 6,057,305; 6,703,396; 7,390,791; 7,803,788…obviousness-type double patenting rejections for the ’333 Patent, the ’191 Patent, and the ’423 Patent, but was … of the ’191 Patent, the ’333 Patent, and the ’423 Patent, the claims of all Patents-in-Suit are …States Patent and Trademark Office. 20. “Patent(s)-in-Suit” refers to U.S. Patent Nos. 9,044,509…license to a patent allegedly comparable to the Patents-in-Suit and any license to a patent relating External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.